Acurx Pharmaceuticals, Inc. Form ARS: Annual report to security holders
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-09-01: Form ARS; Period of report 2025-12-31; Description ARS; Document tm2623641d1_ars.pdf.
- 2025-05-29: Form ARS; Period of report 2024-12-31; Description ARS; Document tm2515246d1_ars.pdf.
- 2024-04-29: Form ARS; Period of report 2023-12-31; Description ARS; Document tm249341d1_ars.pdf.
- 2023-04-27: Form ARS; Period of report 2022-12-31; Description ARS; Document tm13967d1_ars.pdf.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-09-01 | ARS | 2025-12-31 | ARS | tm2623641d1_ars.pdf |
| 2025-05-29 | ARS | 2024-12-31 | ARS | tm2515246d1_ars.pdf |
| 2024-04-29 | ARS | 2023-12-31 | ARS | tm249341d1_ars.pdf |
| 2023-04-27 | ARS | 2022-12-31 | ARS | tm13967d1_ars.pdf |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B |